NRAS and thyroid gland carcinoma: This analysis revealed a heterozygous NRAS Q61K (c.181C > A, rs1219132549) mutation, which is a well-known oncogenic variant in melanomas and thyroid carcinomas [23] that has not been described in PPGLs previously.